Drug Shortage Report for XIAFLEX
Report ID | 66796 |
Drug Identification Number | 02388316 |
Brand name | XIAFLEX |
Common or Proper name | Collagenase Clostridium Histolyticum |
Company Name | ENDO VENTURES LTD. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | Collagenase Clostridium Histolyticum |
Strength(s) | 0.9MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRALESIONAL |
Packaging size | 0.9mg |
ATC code | M09AB |
ATC description | OTHER DRUGS FOR DISORD. OF THE MUSCULO-SKELET.SYST |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-11-12 |
Actual start date | 2018-11-12 |
Estimated end date | 2018-12-12 |
Actual end date | 2018-12-05 |
Shortage status | Resolved |
Updated date | 2018-12-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-11-13 | English | Compare |
v2 | 2018-11-13 | French | Compare |
v3 | 2018-12-05 | English | Compare |
v4 | 2018-12-05 | French | Compare |
v5 | 2018-12-06 | English | Compare |
Showing 1 to 5 of 5